CINTAS PHARMA was formed in 1998. This was because a small group of individuals with many years of experience in Clinical Research, Formulation Development, QA and Regulatory Affairs saw a gap in the marketplace where they can provide expert services at client's premises. Cintas Pharma therefore provides professional help to companies who wish to use the latest tools and techniques efficiently but may be unsure of the steps to take to achieve this major business challenge.

Cintas Pharma is a leading strategic corporate and pharma consultancy practice. Its consultancy has impressive track record in assisting pharmaceutical, biotechnology, medical device, Pharmalicensing and Drug Delivery Technology Companies worldwide with their corporate development activities. In addition Cintas Pharma works with Venture Capital Firms, merchant and clearing Banks, private investors and other providers of finance to the pharmaceutical industry.

Due Diligence investigations are core competence of Cintas in support of

· In-Licensing and Out-Licensing of Products and Technologies
· Mergers and acquisitions
· Business Model Development
· Market and competitors assessments

Examples of Due Diligence that Cintas has performed recently:

Client	Requirements
UK based International Pharma Company	Acquisition of NCE: Technological/Medical and Regulatory Due Diligence
Drug Delivery Technology Company	Acquisition of a new Drug Delivery System. Regulatory/Medical Due Diligence
UK Venture Capital Fund	Private Equity Investment
Generic Drug Company	Acquisitions of Registration File / Due Diligence